Profile of Arturo Casadevall.
作者信息
Williams Sarah C P
出版信息
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2418187121. doi: 10.1073/pnas.2418187121. Epub 2024 Sep 30.
Abstract
摘要
相似文献
1
Profile of Arturo Casadevall.
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2418187121. doi: 10.1073/pnas.2418187121. Epub 2024 Sep 30.
2
"Anti-virulence" genes--further muddling the lexicon? Response from Arturo Casadevall and Liise-anne Pirofski.
Trends Microbiol. 2003 Sep;11(9):413-4. doi: 10.1016/s0966-842x(03)00209-9.
3
mGem: A quarter century with the Pirofski-Casadevall damage response framework-a dynamic construct for understanding microbial pathogenesis.
mBio. 2025 Mar 12;16(3):e0294524. doi: 10.1128/mbio.02945-24. Epub 2025 Feb 11.
4
Commentary: the role of epidemiologists in funding biomedical education and research.
Ann Epidemiol. 2016 Sep;26(9):601-4. doi: 10.1016/j.annepidem.2016.07.007. Epub 2016 Jul 20.
5
Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
Expert Rev Anti Infect Ther. 2012 Mar;10(3):319-40. doi: 10.1586/eri.12.11.
6
The Still Underestimated Problem of Fungal Diseases Worldwide.
Front Microbiol. 2019 Feb 12;10:214. doi: 10.3389/fmicb.2019.00214. eCollection 2019.
7
Views of a non-probability sample of corresponding authors with retracted publications in biomedical fields about the impact of different types of retractions on researchers' careers.
An Acad Bras Cienc. 2024 Sep 23;96(suppl 1):e20240038. doi: 10.1590/0001-3765202420240038. eCollection 2024.
8
Erratum for Fang and Casadevall, Research Funding: the Case for a Modified Lottery.
mBio. 2016 May 17;7(3):e00694-16. doi: 10.1128/mBio.00694-16.
9
Correction for Fang and Casadevall, Competitive Science: Is Competition Ruining Science?
Infect Immun. 2015 Nov;83(11):4452. doi: 10.1128/IAI.01031-15.
10
In response to Focosi and Casadevall.
Transfusion. 2022 Aug;62(8):1681-1682. doi: 10.1111/trf.16996.
本文引用的文献
1
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2414957121. doi: 10.1073/pnas.2414957121. Epub 2024 Oct 1.
2
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients.
Life (Basel). 2024 Jun 22;14(7):792. doi: 10.3390/life14070792.
3
Finding evidence for treatment decisions in a pandemic.
Trends Mol Med. 2022 Jul;28(7):536-541. doi: 10.1016/j.molmed.2022.04.008. Epub 2022 May 5.
4
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
N Engl J Med. 2022 May 5;386(18):1700-1711. doi: 10.1056/NEJMoa2119657. Epub 2022 Mar 30.
5
Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
J Clin Invest. 2020 Sep 1;130(9):4791-4797. doi: 10.1172/JCI140200.
6
Reducing bias: accounting for the order of co-first authors.
J Clin Invest. 2019 Apr 29;129(6):2167-2168. doi: 10.1172/JCI128764.
7
Achieving Speaker Gender Equity at the American Society for Microbiology General Meeting.
mBio. 2015 Aug 4;6(4):e01146. doi: 10.1128/mBio.01146-15.
8
Misconduct accounts for the majority of retracted scientific publications.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17028-33. doi: 10.1073/pnas.1212247109. Epub 2012 Oct 1.
9
Fungi and the rise of mammals.
PLoS Pathog. 2012;8(8):e1002808. doi: 10.1371/journal.ppat.1002808. Epub 2012 Aug 16.
10
Amoeba provide insight into the origin of virulence in pathogenic fungi.
Adv Exp Med Biol. 2012;710:1-10. doi: 10.1007/978-1-4419-5638-5_1.
Zotero 插件